Optimizing Postcardiac Transplantation Outcomes in Children with Ventricular Assist Devices: How Long Should the...

Area of Science:

• Cardiology
• Pediatric Transplant Surgery
• Medical Devices

Background:

• Ventricular assist devices (VADs) are crucial for reducing mortality in pediatric heart transplant candidates.
• VADs improve end-organ function, but optimal support duration for post-transplant outcomes is not well-defined.

Purpose of the Study:

• To determine the ideal duration of VAD support for optimizing outcomes in pediatric heart transplant recipients.
• To identify specific timeframes of VAD support associated with improved post-transplant survival and reduced complications.

Main Methods:

• Analysis of pediatric heart transplant recipients from the United Network for Organ Sharing database (n=685).
• Utilized cubic spline fitting to determine mortality hazard inflection points based on VAD support duration.
• Compared outcomes based on VAD support duration categories (<2 months, 2-4 months, >4 months) and device type (pulsatile vs. continuous flow).

Main Results:

• VAD support >2 months significantly decreased inotrope use, mechanical ventilation, and improved functional status (p < 0.001).
• Support for 2-4 months correlated with better post-transplant survival compared to <2 months (p = 0.031).
• Continuous flow devices showed optimal outcomes with >3 weeks of support, improving end-organ function and survival (p < 0.001, p = 0.014).

Conclusions:

• A period of VAD support prior to listing for heart transplantation is associated with improved pre-transplant risk factors and enhanced post-transplant survival.
• Optimizing VAD support duration, particularly 2-4 months for pulsatile devices and >3 weeks for continuous flow, is critical for pediatric heart transplant success.
• This study suggests a strategic approach to VAD support duration can significantly improve long-term outcomes for pediatric heart transplant recipients.